查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1598523

移植市场：依产品、应用和最终用途 – 2025-2030 年全球预测

Transplantation Market by Product (Immunosuppressive Drugs, Tissue Products), Application (Organ Transplantation, Tissue Transplantation), End Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年移植市值为286.7亿美元，预计2024年将达到310.9亿美元，复合年增长率为8.53%，预计到2030年将达到508.6亿美元。

移植是一种医疗程序，将器官或组织从一个身体移植到另一个身体，或从供体部位移植到患者体内的另一个位置，以替换受损或功能障碍的器官，目的是恢復。移植的需要主要源自于慢性疾病、急性损伤或导致器官衰竭的先天性缺陷。研究应用包括肾臟、肝臟、心臟、肺臟和胰臟移植，主要最终使用领域为医院、移植中心和研究机构。市场驱动因素包括慢性病盛行率上升、移植技术的进步以及医疗基础设施意识和投资的增加。再生医学以及透过组织工程和 3D 列印开发生物人工器官正在涌现商机，并且有望透过缓解捐赠者短缺来改变游戏规则。

主要市场统计
基准年[2023] 286.7亿美元
预测年份 [2024] 310.9亿美元
预测年份 [2030] 508.6亿美元
复合年增长率（%） 8.53%

然而，市场成长受到诸如严格的监管要求、高成本以及围绕器官捐赠和分配的道德问题等挑战的限制。此外，免疫排斥和长期併发症仍然是主要的临床挑战。为了利用潜在的商机，相关人员应关注免疫抑制治疗的创新，并制定提高捐赠者意识的策略。当生技公司和医疗保健提供者合作研究异种移植和干细胞疗法时，可能会有显着的成长前景。此外，器官保存和运输技术等领域为减少移植延误和提高器官活力提供了有希望的途径。随着市场的发展，公司应优先考虑患者教育和支持计划，以提高移植成功率和接受者的生活质量，从而在竞争格局中占据有利地位。由于技术的快速进步和医疗保健政策的变化，市场动态变得越来越活跃，需要不断创新和适应才能保持竞争力。

市场动态：揭示快速发展的移植市场的关键市场洞察

供需的动态交互作用正在改变移植市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助消费行为及其对製造业的影响。

  • 市场驱动因素
    • 慢性病盛行率增加
    • 器官捐赠与登记意识不断增强
    • 组织库增加
  • 市场限制因素
    • 缺乏治疗器官衰竭的器官捐赠
  • 市场机会
    • 移植手术技术不断进步
    • 各国政府和非政府组织加强积极努力
  • 市场挑战
    • 与移植相关的伦理和文化问题日益增多

波特五力：驾驭移植市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解移植市场的外部影响

外部宏观环境因素在塑造移植市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解移植市场的竞争状况

对移植市场的详细市场占有率分析可以对供应商绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵置入市场厂商绩效评估

FPNV定位矩阵是评估移植市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议绘製移植市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，移植市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病增加
      • 器官捐赠与登记意识不断增强
      • 组织库建置进展
    • 抑制因素
      • 缺乏治疗器官衰竭的器官捐赠
    • 机会
      • 移植手术的技术进步
      • 各国政府和非政府组织加强积极努力
    • 任务
      • 与移植相关的伦理和文化问题日益增多
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章移植市场：副产品

  • 免疫抑制药物
  • 纸巾产品

第七章移植市场：依应用分类

  • 器官移植
  • 组织移植

第八章移植市场：依最终用途分类

  • 医院
  • 移植中心

第九章美洲移植市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太移植市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲移植市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Arthrex, Inc.
  • Australian Red Cross Lifeblood
  • BioLife Solutions Inc.
  • Dr. Franz Kohler Chemie GmbH
  • LifeCell International Pvt. Ltd.
  • Mid-America Transplant
  • Novartis AG
  • Sanofi SA
  • Stryker Corporation
  • Terumo Corporation
  • Teva Pharmaceutical Industries Ltd
  • TransMedics, Inc.
  • Veloxis Pharmaceuticals
  • Zimmer Biomet
Product Code: MRR-031685195793

The Transplantation Market was valued at USD 28.67 billion in 2023, expected to reach USD 31.09 billion in 2024, and is projected to grow at a CAGR of 8.53%, to USD 50.86 billion by 2030.

Transplantation refers to the medical procedure wherein an organ or tissue is transferred from one body to another or from a donor site to another location in the patient's body, aimed at replacing damaged or failing organs to restore functionality. The necessity for transplantation arises primarily from chronic diseases, acute injuries, or congenital defects resulting in organ failure. Applications include kidney, liver, heart, lung, and pancreas transplants, with major end-use areas being hospitals, transplant centers, and research institutes. Significant market drivers include the rising prevalence of chronic diseases, advancements in transplantation technology, and increasing awareness and investments in healthcare infrastructure. Opportunities are emerging from regenerative medicine and the development of bioartificial organs through tissue engineering and 3D printing, which are poised to transform the landscape by alleviating donor organ shortages.

KEY MARKET STATISTICS
Base Year [2023] USD 28.67 billion
Estimated Year [2024] USD 31.09 billion
Forecast Year [2030] USD 50.86 billion
CAGR (%) 8.53%

However, market growth is constrained by challenges, such as stringent regulatory requirements, high costs, and ethical concerns around organ donation and allocation. Furthermore, immunological rejection and long-term complications remain significant clinical challenges. To capitalize on potential opportunities, stakeholders should focus on innovation in immunosuppressive therapies and develop strategies to increase donor awareness. Collaboration between biotechnology firms and healthcare providers for research in xenotransplantation and stem cell therapy could unlock significant growth prospects. Moreover, areas like organ preservation and transport technologies offer promising avenues for reducing transplant delays and enhancing organ viability. As the market evolves, companies should prioritize patient education and support programs to improve transplant success rates and quality of life for recipients, thus positioning themselves advantageously within the competitive landscape. The nature of the transplantation market is increasingly dynamic, shaped by fast-paced technological advancements and shifting healthcare policies, necessitating continuous innovation and adaptation to remain competitive.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Transplantation Market

The Transplantation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of chronic diseases
    • Growing awareness about organ donation and registration
    • Rising development of tissue banks
  • Market Restraints
    • Shortage of organ donation for treatment of organ failure
  • Market Opportunities
    • Rising technological advancement in transplant surgeries
    • Growing active initiatives by government and non-government organizations
  • Market Challenges
    • Growing ethical and cultural issues associated with transplantations

Porter's Five Forces: A Strategic Tool for Navigating the Transplantation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Transplantation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Transplantation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Transplantation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Transplantation Market

A detailed market share analysis in the Transplantation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Transplantation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Transplantation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Transplantation Market

A strategic analysis of the Transplantation Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Transplantation Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Arthrex, Inc., Australian Red Cross Lifeblood, BioLife Solutions Inc., Dr. Franz Kohler Chemie GmbH, LifeCell International Pvt. Ltd., Mid-America Transplant, Novartis AG, Sanofi S.A., Stryker Corporation, Terumo Corporation, Teva Pharmaceutical Industries Ltd, TransMedics, Inc., Veloxis Pharmaceuticals, and Zimmer Biomet.

Market Segmentation & Coverage

This research report categorizes the Transplantation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Immunosuppressive Drugs and Tissue Products.
  • Based on Application, market is studied across Organ Transplantation and Tissue Transplantation.
  • Based on End Use, market is studied across Hospitals and Transplant Centers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases
      • 5.1.1.2. Growing awareness about organ donation and registration
      • 5.1.1.3. Rising development of tissue banks
    • 5.1.2. Restraints
      • 5.1.2.1. Shortage of organ donation for treatment of organ failure
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising technological advancement in transplant surgeries
      • 5.1.3.2. Growing active initiatives by government and non-government organizations
    • 5.1.4. Challenges
      • 5.1.4.1. Growing ethical and cultural issues associated with transplantations
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Transplantation Market, by Product

  • 6.1. Introduction
  • 6.2. Immunosuppressive Drugs
  • 6.3. Tissue Products

7. Transplantation Market, by Application

  • 7.1. Introduction
  • 7.2. Organ Transplantation
  • 7.3. Tissue Transplantation

8. Transplantation Market, by End Use

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Transplant Centers

9. Americas Transplantation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Transplantation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Transplantation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Arthrex, Inc.
  • 3. Australian Red Cross Lifeblood
  • 4. BioLife Solutions Inc.
  • 5. Dr. Franz Kohler Chemie GmbH
  • 6. LifeCell International Pvt. Ltd.
  • 7. Mid-America Transplant
  • 8. Novartis AG
  • 9. Sanofi S.A.
  • 10. Stryker Corporation
  • 11. Terumo Corporation
  • 12. Teva Pharmaceutical Industries Ltd
  • 13. TransMedics, Inc.
  • 14. Veloxis Pharmaceuticals
  • 15. Zimmer Biomet

LIST OF FIGURES

  • FIGURE 1. TRANSPLANTATION MARKET RESEARCH PROCESS
  • FIGURE 2. TRANSPLANTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. TRANSPLANTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL TRANSPLANTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL TRANSPLANTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. TRANSPLANTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL TRANSPLANTATION MARKET SIZE, BY IMMUNOSUPPRESSIVE DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL TRANSPLANTATION MARKET SIZE, BY ORGAN TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL TRANSPLANTATION MARKET SIZE, BY TISSUE TRANSPLANTATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL TRANSPLANTATION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL TRANSPLANTATION MARKET SIZE, BY TRANSPLANT CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES TRANSPLANTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA TRANSPLANTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM TRANSPLANTATION MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
  • TABLE 143. TRANSPLANTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. TRANSPLANTATION MARKET, FPNV POSITIONING MATRIX, 2023